A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up

Journal of Traditional Chinese Medicine

Volumn 32, Issue 2, 2012, Pages 156-163

  Sun, Zhen ^a,b   Liang, Shui Ting ^c   Zhai, Xiao Feng ^b   Lang, Qing Bo ^b   Zhou, Qing Hui ^b   Yue, Xiao Qiang ^b   He, Jia ^d   Xu, Jing ^c   Zhu, Yi ^a   Ling, Chang Quan ^b,e  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e E Institutes of Shanghai Municipal Education Commission   (China)

Author keywords

Hepatocellular carcinoma; Herbal therapy; Interventional therapy; Prognostic factors; Traditional Chinese medicine

Indexed keywords

HERBACEOUS AGENT; RUANJIANHUGAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER THERAPY; CHINESE MEDICINE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INTERVENTIONAL THERAPY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THERAPY EFFECT; TUMOR VOLUME;

EID: 84863575227     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60005-9     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108
2. Qing LX, Sun HC, Tang ZY. Progress in research on the treatment of primary liver cancer-the meeting minutes of 2006 Shanghai-Hong Kong International Hepatopathy. Chinese J Surg 2006; 44: 1070
3. Yu YQ, Tang ZY, Zhou XD. Experience in resection of small hepatocellular carcinoma. Chin Med J 1980; 93: 491-494
4. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang R, Lu JZ, Lin ZY, Yang BH. Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 1989; 64: 546-541
5. Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 1989; 64: 546-541
6. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200
7. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002; 3: 593-603
8. Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, Zhou J, Qiu SJ, Li Y, Ji XN, Liu H, Xia JL, Wu ZQ, Fan J, Ma ZC, Zhou XD, Lin ZY, Liu KD. A decade, s studies on metastasis of hepatocellular carcinoma. J Cancer Res Cli Oncol 2004; 130: 187-196
9. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006; 23: 1535-1547
10. Ling CQ. Problems in cancer treatment and major research of integrative medicine. J Chin Integr Med 2003; 1: 168-170
11. Chen Z, Li B, Yue XQ, Zhu DZ, Yu CQ, Wu MC, Ling CQ. A retrospective control analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages. J Altern Complement Med 2006; 12: 941-942
12. Xiao KY. Advance in the epidemiologic characteristics of primary liver cancer. Chin J Bases Clin General Surg 2000; 7: 272-274
13. Tang ZY. Clinical research of hepatocellular carcinoma. Chinese Journal of Hepatology 2006; 14: 481-482
14. The Chinese Ministry of Health of China. Ethical review of biomedical research involving human subjects; 2007: 17
15. Tang ZY. The study prospect of small hepatocellular carcinoma. J Clin Res 2003; 20: 643-644
16. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, Wu ZQ, Fan J, Qin LX, Zhang BH. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91: 1479-1486
17. Ye SL, Qin SK, Wu MC. Expert consensus on standardization of the management of primary liver cancer. Tumor 2009; 29: 299-300
18. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, Peng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82: 122-126
19. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48: S20-37
20. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008; 105: 4826-4831
21. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13: 353-61
22. Hui KK, Hui EK, Johnston MF. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-West medicine. Integr Cancer Ther 2006; 5: 56-62
23. Xiao KY, Li LQ, Peng MH, Yang DH, Liang ST, Qin X, Chen XG, Guo Y, Qin Z, Peng T, Chen B, Su ZX, Shang LM. The family history and the clinical characteristics of 101 patients of hepatocellular carcinoma with family aggregation (FH). Journal of Guangxi Medical University 2005; 22: 224-226
24. Sun Z, Su YH, Yue XQ. Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication. J Chin Integr Med 2008; 6: 1221-1225
25. Ling CQ. Cancerous toxin is the key pathogenic factor of malignant tumor. J Chin Integr Med/Zhong Xi Yi Jie He Xue Bao 2008; 6: 111-114
26. Yu Y, Lang QB, Chen Z, Li B, Yu CQ, Zhu DZ, Huang XQ, Zhai XF, Ling CQ. The efficacy for unresectable Hepatocellular Carcinoma maybe improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula. Cancer 2009; 115: 5132-5138
27. Tang ZY. Perspective of clinical oncology from the viewpoint of liver cancer studies. Tumor 2009; 29: 1-3
28. Guo QQ, Liang ST, Liang XJ, Yu H. The experimental research to prevent the formation of liver fibrosis. Journal of Guangxi Medical University 2007; 24: 261-263
29. Liang ST, Qin X, Li LQ, Lu YF, Qin Z, Ling JL, Wu S, Liang XJ, Zhou HS. The precentive effect of RuanJian-HuGanPian and GanCaoTianSuPian on postoperative recurrence in hepatocellular carcinoma. Chin J Clin Hepatol 2004; 20: 293-294
30. Fan J, Zhou J, Wu ZQ, Tang ZY, Zhou XD, Ma ZC, Qin LX, Wang Z. Surgical treatment of primary hepatocellular carcinoma: 20-year clinical experience in 7566 patients. Chin J Dig Surg 2009; 4: 99